Brief: Instil Bio Announce Closure Of Its UK Manufacturing And Clinical Operations

Instil Bio

16/01/2024 13:04

Jan 16 (Reuters) - Instil Bio Inc  TIL.O :
    * INSTIL BIO ANNOUNCES STRATEGIC UPDATE
    * INSTIL BIO INC - WITH OBJECTIVE OF SAVING COSTS, IMPROVING
TIME
EFFICIENCY, ANNOUNCING CLOSURE OF ITS UK MANUFACTURING AND
CLINICAL OPERATIONS
    * INSTIL BIO INC: ANNOUNCING CLOSURE OF ITS UK MANUFACTURING
AND
CLINICAL OPERATIONS
    * INSTIL BIO INC - REDUCING ITS UK WORKFORCE WHICH IS
EXPECTED TO
BE SUBSTANTIALLY COMPLETED BY FIRST HALF OF 2024
    * INSTIL BIO INC: REDUCING ITS UK WORKFORCE WHICH IS
EXPECTED TO
BE SUBSTANTIALLY COMPLETED BY FIRST HALF OF 2024
    * INSTIL BIO: TO RETAIN PROCESS DEVELOPMENT, RESEARCH
PERSONNEL TO
ADVANCE EARLY-STAGE PIPELINE DEVELOPMENT OF COSTAR, OTHER NOVEL
TIL TECHNOLOGIES
    * INSTIL BIO INC: ENTERED INTO AN AGREEMENT WITH A
COLLABORATOR TO
CONDUCT PRECLINICAL MANUFACTURING FEASIBILITY STUDIES IN
ITIL-306 PROGRAM

Source text for Eikon:  ID:nGNX11mNPq 
Further company coverage:  TIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))